Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo

Journal of Experimental Medicine

Volumn 190, Issue 1, 1999, Pages 9-19

  Estess, Pila ^a   Nandi, Animesh ^a   Mohamadzadeh, Mansour ^a   Siegelman, Mark H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD44; Endothelial cell; Hyaluronate; Interleukin 15; Lymphocyte adhesion

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 15; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CYTOKINE RELEASE; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHEAR STRESS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD44; CATTLE; CELL LINE; CELL TRANSFORMATION, VIRAL; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; INTERLEUKIN-15; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; PERITONEAL CAVITY; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; SIMIAN VIRUS 40; T-LYMPHOCYTES;

EID: 0033526776     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.1.9     Document Type: Article

References (43)

1. DeGrendele, H.C., P. Estess, L.J. Picker and M.H. Siegelman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte/endothelial cell primary adhesion pathway. J. Exp. Med. 183:1119-1130.
2. DeGrendele, H.C., P. Estess and M.H. Siegelman. 1997. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol. 159:2549-2553.
3. DeGrendele, H.D., P. Estess, and M.H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflamed site. Science. 278:672-675.
4. Mohamadzadeh, M., H.C. DeGrendele, P. Estess, and M.H. Siegelman. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA dependent primary adhesion. J. Clin. Invest. 101:97-108.
5. Estess, P., H.C. DeGrendele, V. Pascual, and M.H. Siegelman. 1998. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J. Clin. Invest. 102:1173-1182.
6. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 264:965-968.
7. Burton, J.D., R.N. Bamford, C. Peters, A.J. Grant, G. Kurys, C.K. Goldman, J. Brennan, E. Roessler, and T.A. Waldmann. 1994. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA. 91: 4935-4939.
8. McInnes, I.B., and F.Y. Liew. 1998. Interleukin 15 - a proinflammatory role in rheumatoid arthritis synovitis. Immunol. Today. 19:75-79.
9. Vella, A.T., S. Dow, T.A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 95:3810-3815.
10. Bulfone-Paus, S., D. Ungureanu, T. Pohl, G. Lindner, R. Paus, R. Ruckert, H. Krause, and U. Kunzendorf. 1997. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3:1124-1128.
11. Quinn, L.S., K.L. Haugk, and K.H. Grabstein. 1995. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology. 136:3669-3672.
12. Angiolillo, A.L., H. Kanegane, C. Sgadari, G.H. Reaman, and G. Tosato. 1997. Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res. Commun. 233:231-237.
13. McInnes, I.B., J. al-Mughales, M. Field, B.P. Leung, F.P. Huang, R. Dixon, R.D. Sturrock, P.C. Wilkinson, and F.Y. Liew. 1996. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2:175-182.
14. Ruchatz, H., B.P. Leung, X.Q. Wei, I.B. McInnes, and F.Y. Liew. 1998. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis - a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160:5654-5660.
15. Tagaya, Y., R.N. Bamford, A.P. DeFilippis, and T.A. Waldmann. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4:329-336.
16. Mohamadzadeh, M., M.J. McGuire, I. Dougherty, and P.J. Cruz. 1996. Interleukin-15 expression by human endothelial cells: up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol. Photoimmunol. Photomed. 12: 17-21.
17. Green, S.J., G. Tarone, and C.B. Underhill. 1988. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J. Cell Sci. 90:145-156.
18. Miyake, K., K.L. Medina, S. Hayashi, S. Ono, T. Hamaoka, and P.W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477-488.
19. Takei, F. 1985. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 134:1403-1407.
20. Miyake, K., K. Medina, K. Ishihara, M. Kimoto, R. Auerbach, and P.W. Kincade. 1991. A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. 114: 557-565.
21. O'Connell, K.A., and M. Edidin. 1990. A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J. Immunol. 144:521-525.
22. Harder, R., H. Uhlig, A. Kashan, B. Schutt, A. Duijvestijn, E.C. Butcher, H.G. Thiele, and A. Hamann. 1991. Dissection of murine lymphocyte-endothelial cell interaction mechanisms by SV-40-transformed mouse endothelial cell lines: novel mechanisms mediating basal binding, and alpha 4-integrin-dependent cytokine-induced adhesion. Exp. Cell Res. 197:259-267.
23. Ager, A. 1987. Isolation and culture of high endothelial cells from rat lymph nodes. J. Cell Sci. 87:133-144.
24. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
25. Saiki, R.K., T.L. Bugawan, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1986. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA DNA with allele-specific oligonucleotide probes. Nature. 324:163-166.
26. Jones, D.A., O. Abbassi, L.V. McIntire, R.P. McEver, and C.W. Smith. 1993. P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys. J. 65:1560-1569.
27. Suzuki, H., T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J. Simard, P.S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1472-1476.
28. Tagaya, Y., J.D. Burton, Y. Miyamoto, and T.A. Waldmann. 1996. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:4928-4939.
29. McInnes, I.B., B.P. Leung, R.D. Sturrock, M. Field, and F.Y. Liew. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 3:189-195.
30. Oppenheimer-Marks, N., R.I. Brezinschek, M. Mohamadzadeh, R. Vita, and P.E. Lipsky. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the scid mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 101:1261-1272.
31. Pober, J.S., and R.S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427-451.
32. Mantovani, A., F. Bussolino, and E. Dejana. 1992. Cytokine regulation of endothelial cell function. FASEB J. 6:2591-2599.
33. Carlos, T.M., and J.M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood. 84:2068-2101.
34. Dinarello, C.A. 1994. To Sheldon M. Wolff, as we commemorate the 10th anniversary of the clonings of IL-1 alpha and IL-1 beta. Eur. Cytokine Netw. 5:513-516.
35. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:472-475.
36. Gin, J.G., D.M. Anderson, S. Kumaki, L.S. Park, K.H. Grabstein, and D. Cosman. 1995. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukocyte Biol. 57:763-766.
37. Wilkinson, P.C., and F.Y. Liew. 1995. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255-1259.
38. Akbar, A.N., N.J. Borthwick, R.G. Wickremasinghe, P. Panayoitidis, D. Pilling, M. Bofill, S. Krajewski, J.C. Reed, and M. Salmon. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur. J. Immunol. 26:294-299.
39. + T cells in vivo by IL-15. Immunity. 8:591-599.
40. Agostini, C., L. Trentin, M. Facco, R. Sancetta, A. Cerutti, C. Tassinari, L. Cimarosto, F. Adami, A. Cipriani, R. Zambello, and G. Semenzato. 1996. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157:910-918.
41. Kirman, I., and O.H. Nielsen. 1996. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91:1789-1794.
42. Elliott, M.J., R.N. Maini, M. Feldmann, J.R. Kalden, C. Antoni, J.S. Smolen, B. Leeb, F.C. Breedveld, J.D. MacFarlane, and H. Bijl. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1105-1110.
43. Elliott, M.J., R.N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Bijl, and J.N. Woody. 1994. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet. 344:1125-1127.